Literature DB >> 19876069

Granzymes and perforin in solid organ transplant rejection.

J C Choy1.   

Abstract

Rejection of solid organ allografts by the recipient immune system is mediated, to a major extent, by T cell effector mechanisms. Granzymes and perforin are protein regulators of cytotoxic T lymphocyte-mediated target cell death. In this review, I discuss clinical data implicating granzymes and perforin in acute and chronic solid organ transplant rejection, as well as data from cell and animal experiments that support a main role for these effector molecules in allograft rejection.

Mesh:

Substances:

Year:  2009        PMID: 19876069     DOI: 10.1038/cdd.2009.161

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  25 in total

1.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

2.  Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejection.

Authors:  Steve Oghumu; Uday Nori; Anna Bracewell; Jianying Zhang; Cherri Bott; Gyongyi M Nadasdy; Sergey V Brodsky; Ronald Pelletier; Abhay R Satoskar; Tibor Nadasdy; Anjali A Satoskar
Journal:  Clin Transplant       Date:  2016-08-08       Impact factor: 2.863

3.  Mouse model of alloimmune-induced vascular rejection and transplant arteriosclerosis.

Authors:  Winnie Enns; Anna von Rossum; Jonathan Choy
Journal:  J Vis Exp       Date:  2015-05-17       Impact factor: 1.355

4.  Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response.

Authors:  Joo Youn Oh; Ryang Hwa Lee; Ji Min Yu; Jung Hwa Ko; Hyun Ju Lee; Ah Young Ko; Gavin W Roddy; Darwin J Prockop
Journal:  Mol Ther       Date:  2012-08-28       Impact factor: 11.454

5.  Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.

Authors:  Kevin Rey; Sukhbir Manku; Winnie Enns; Thea Van Rossum; Kevin Bushell; Ryan D Morin; Fiona S L Brinkman; Jonathan C Choy
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

6.  Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation.

Authors:  Esilida Sula Karreci; Siawosh K Eskandari; Farokh Dotiwala; Sujit K Routray; Ahmed T Kurdi; Jean Pierre Assaker; Pavlo Luckyanchykov; Albana B Mihali; Omar Maarouf; Thiago J Borges; Abdullah Alkhudhayri; Kruti R Patel; Amr Radwan; Irene Ghobrial; Martina McGrath; Anil Chandraker; Leonardo V Riella; Wassim Elyaman; Reza Abdi; Judy Lieberman; Jamil Azzi
Journal:  JCI Insight       Date:  2017-11-02

7.  Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.

Authors:  J Azzi; S Ohori; C Ting; M Uehara; R Abdoli; B D Smith; K Safa; Z Solhjou; P Lukyanchykov; J Patel; M McGrath; R Abdi
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

8.  Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.

Authors:  Kyoung Un Park; Ping Jin; Marianna Sabatino; Ji Feng; Sara Civini; Hanh Khuu; Maria Berg; Richard Childs; David Stroncek
Journal:  J Immunother       Date:  2010 Nov-Dec       Impact factor: 4.456

9.  Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice.

Authors:  P R Hiebert; D Wu; D J Granville
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

10.  Bim regulates alloimmune-mediated vascular injury through effects on T-cell activation and death.

Authors:  Anna von Rossum; Winnie Enns; Yu P Shi; Grace E MacEwan; Mehrnoush Malekesmaeli; Ryan Brinkman; Jonathan C Choy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.